FAQ

Serotonin-4 Receptor Antagonist [EPC]

Known as: Serotonin subtype 4 (5HT-4) Receptor Antagonist, 5HT-4 Receptor Antagonist, Serotonin-4 Receptor Antagonist 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1974-2017
01219742017

Related topics

Related topics

1 relation
Serotonin 4 Receptor Antagonists [MoA]

Related mentions per year

Related mentions per year

1974-2017
197019801990200020102020
Serotonin-4 Receptor Antagonist [EPC]
Serotonin 4 Receptor Antagonists [MoA]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
GnRH antagonist associates with less adiposity and reduced characteristics of metabolic syndrome and atherosclerosis compared with orchiectomy and GnRH agonist in a preclinical mouse model.
OBJECTIVES Observational studies relate androgen deprivation therapy (ADT) to metabolic syndrome (MS) and cardiovascular disease… (More)
Is this relevant?
2014
2014
Gene expression analysis of bovine oocytes at optimal coasting time combined with GnRH antagonist during the no-FSH period.
Ovarian stimulation with FSH combined with an appropriate period of FSH withdrawal (coasting) before ovum pick-up now appears to… (More)
  • figure 1
  • table 1
  • figure 2
  • table 3
  • table 2
Is this relevant?
2012
2012
Interleukin-1 receptor type-1 in non-hematopoietic cells is the target for the pro-atherogenic effects of interleukin-1 in apoE-deficient mice.
OBJECTIVES Interleukin (IL)-1 produced by vascular and bone marrow-derived cells exerts proinflammatory effects in these cell… (More)
Is this relevant?
2009
2009
[Increased risk of early pregnancy loss and lower live birth rate with GNRH antagonist vs. long GNRH agonist protocol in PCOS women undergoing controlled ovarian hyperstimulation].
AIM to compare standard long GnRH agonist protocol (Triptorelin) and GnRH antagonist regimens (Cetrorelix) in polycystic ovary… (More)
Is this relevant?
2005
2005
Minimal stimulation IVF with late follicular phase administration of the GnRH antagonist cetrorelix and concomitant substitution with recombinant FSH: a pilot study.
BACKGROUND The use of the natural cycle for IVF offers the advantage of a patient-friendly and low-risk protocol. Its… (More)
Is this relevant?
2005
2005
GnRH antagonist-induced down-regulation of the mRNA expression of pituitary receptors: comparisons with GnRH agonist effects.
In order to compare the mechanism for the down regulation of the mRNA expression of pituitary receptors induced by GnRH… (More)
Is this relevant?
2002
2002
The ET(A) receptor antagonist LU 135252 has no electrophysiological or anti-arrhythmic effects during myocardial ischaemia/reperfusion in dogs.
The anti-arrhythmic effects of ET(A) receptor antagonists during myocardial ischaemia and reperfusion remain controversial… (More)
Is this relevant?
2001
2001
Hypothalamic dopaminergic receptor expressions in anorexia of tumor-bearing rats.
Our past microdialysis studies in ventromedial hypothalamic nucleus (VMN) and lateral hypothalamic area (LHA) of changes in… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
1994
1994
Can testosterone alone maintain the gonadotrophin-releasing hormone antagonist-induced suppression of spermatogenesis in the non-human primate?
The combination of gonadotrophin-releasing hormone (GnRH) antagonist and delayed testosterone substitution provides a promising… (More)
Is this relevant?
1974
1974
Reversal by Narcotic Antagonist of a Narcotic Action elicited by a Conditional Stimulus
THERE is considerable evidence to indicate that learning is important in narcotic dependence1. However, there has been little… (More)
Is this relevant?